Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
15 October 2021Website:
http://paragon28.comNext earnings report:
28 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | 118 min agoDividend
Analysts recommendations
Institutional Ownership
FNA Latest News
NEW YORK, NY / ACCESSWIRE / November 21, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=113061&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / November 21, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=113050&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK CITY, NY / ACCESSWIRE / November 21, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Paragon 28 securities between May 5, 2023 through September 20, 2024, inclusive (the "Class Period").
NEW YORK, NY / ACCESSWIRE / November 20, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112911&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112657&wire=1 or contact Joseph E. Levi, Esq.
LOS ANGELES , Nov. 19, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Paragon 28, Inc. ("Paragon" or the "Company") (NYSE: FNA). Class Period: May 5, 2023 – September 20, 2024 Lead Plaintiff Deadline: November 29, 2024 If you wish to serve as lead plaintiff of the Paragon lawsuit, you can submit your contact information at www.glancylaw.com/cases/Paragon-28-Inc/.
NEW YORK , Nov. 19, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Paragon 28, Inc. (NYSE: FNA) between May 5, 2023 and September 20, 2024, both dates inclusive (the "Class Period"), and those who purchased Paragon 28 call options or sold put options during the Class Period, of the November 29, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased Paragon 28 securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112564&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / November 19, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112618&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / November 18, 2024 / If you suffered a loss on your Paragon 28, Inc. (NYSE:FNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/paragon-28-inc-lawsuit-submission-form?prid=112511&wire=1 or contact Joseph E. Levi, Esq.
What type of business is Paragon 28?
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
What sector is Paragon 28 in?
Paragon 28 is in the Healthcare sector
What industry is Paragon 28 in?
Paragon 28 is in the Medical Devices industry
What country is Paragon 28 from?
Paragon 28 is headquartered in United States
When did Paragon 28 go public?
Paragon 28 initial public offering (IPO) was on 15 October 2021
What is Paragon 28 website?
https://paragon28.com
Is Paragon 28 in the S&P 500?
No, Paragon 28 is not included in the S&P 500 index
Is Paragon 28 in the NASDAQ 100?
No, Paragon 28 is not included in the NASDAQ 100 index
Is Paragon 28 in the Dow Jones?
No, Paragon 28 is not included in the Dow Jones index
When was Paragon 28 the previous earnings report?
No data
When does Paragon 28 earnings report?
The next expected earnings date for Paragon 28 is 28 February 2025